Triptorelin Embonate (6-Month Formulation)

By Keating Gillian M.  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 347-353

Adis International

Access to resources Recommend Favorite

Triptorelin embonate (6-month formulation): a guide to its use in advanced prostate cancer

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 6, 2010-06 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer: An Open-Label, Non-Comparative, Multicentre, Phase III Study

By Lundström Eija A.  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 757-765

Adis International

Access to resources Recommend Favorite

Letrozole plus triptorelin suppresses estrogen to a greater extent than tamoxifen and triptorelin in premenopausal women with early breast cancer

By  

Inpharma, Vol. 1, Iss. 1623, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Docetaxel plus estramustine and 15-month androgen deprivation therapy is feasible for the treatment of early prostate cancer relapse

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite